Paydirt
NTLA
Ticker

Intellia Therapeutics, Inc.

NTLA · Healthcare · Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics usi…

Intellia Therapeutics, Inc. (NTLA), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 5 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 3. The most active filer was John M Leonard with 4 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
6
1 buy · 5 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$3.0M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Nov 2
Filed Nov 3
ADViAverage daily dollar volume
$62.4M
market data
Share price · 12M
$11.35 (+16.6%)
$17.84$12.94$8.04Nov 10 2025May 12Nov 6

Adjusted for splits and dividends.

Volume by month
$1.4M$701K$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2025 · sells $552KJul 2025 · sells $105KAug 2025 · buys $1.0MDec 2025 · sells $785KJan 2026 · buys $1.4MJan 2026 · sells $424KAug 2026 · sells $251KNov 2026 · sells $108K
Buys $2.4M Sells $2.2M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
JL John M Leonard President and CEO 5 filings · 0 buys, 5 sales DL David Lebwohl EVP, Chief Medical Officer 2 filings · 0 buys, 2 sales WC William J Chase Director 1 filing · 1 buy, 0 sales FC Fred E Cohen Director 1 filing · 1 buy, 0 sales EI Edward J Dulac III EVP, Chief Financial Officer 1 filing · 0 buys, 1 sale LL Laura Sepp-Lorenzino EVP, Chief Scientific Officer 1 filing · 0 buys, 1 sale
Recent filings
John M LeonardSALE President and CEO $108K
9,000 sh × $11.99
Exec Nov 2
Filed Nov 3 · 4:20 PM ET John M LeonardSALE President and CEO $251K
19,890 sh × $12.60
Exec Aug 20
Filed Aug 24 · 4:05 PM ET David LebwohlSALE EVP, Chief Medical Officer $110K
11,903 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET John M LeonardSALE President and CEO $314K
34,146 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET Fred E CohenPURCHASE Director $1.4M
150,000 sh × $9.35
Exec Jan 5
Filed Jan 7 · 4:05 PM ET John M LeonardSALE President and CEO $785K
82,791 sh across 2 lots
Exec Dec 11 2025
Filed Dec 12 2025 · 5:30 PM ET William J ChasePURCHASE Director $1.0M
100,000 sh × $10.03
Exec Aug 20 2025
Filed Aug 22 2025 · 4:30 PM ET Edward J Dulac IIISALE EVP, Chief Financial Officer $105K
7,462 sh × $14.02
Exec Jul 23 2025
Filed Jul 25 2025 · 5:30 PM ET Laura Sepp-LorenzinoSALE EVP, Chief Scientific Officer $109K
8,966 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET John M LeonardSALE President and CEO $327K
26,807 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET David LebwohlSALE EVP, Chief Medical Officer $116K
9,557 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET